How have ENDV shares performed in 2024?

Endonovo Therapeutics' stock was trading at $0.0087 on January 1st, 2024. Since then, ENDV shares have decreased by 63.2% and is now trading at $0.0032. View the best growth stocks for 2024 here .

What other stocks do shareholders of Endonovo Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Endonovo Therapeutics investors own include Chesapeake Energy (CHKAQ) , Energous (WATT) , Advanced Micro Devices (AMD) , BioLineRx (BLRX) , Ekso Bionics (EKSO) , Geron (GERN) , Marinus Pharmaceuticals (MRNS) , Micron Technology (MU) , Novavax (NVAX) and Exxon Mobil (XOM) .

How do I buy shares of Endonovo Therapeutics?

Shares of ENDV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:ENDV

Endonovo Therapeutics (ENDV) Stock Price, News & Analysis

→ Can't believe it's happening again (From Manward Press) (Ad)

Free ENDV Stock Alerts

$0.0032

0.00 (0.00%)

(As of 04/15/2024 ET)

Compare

Today's Range: $0.0027
▼
$0.0033
50-Day Range: N/A
52-Week Range: $0.00
▼
$0.02

Volume: 281,841 shs
Average Volume: 3.14 million shs
Market Capitalization: $1.07 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials Headlines SEC Filings Short Interest

Get Endonovo Therapeutics alerts:

Ad Manward Press

Can't believe it's happening again

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.

About Endonovo Therapeutics Stock (OTCMKTS:ENDV)

Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of cardiovascular diseases, chronic kidney, liver diseases, non-alcoholic steatohepatitis, cardiovascular and peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, stroke, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.

ENDV Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ENDV Stock News Headlines

March 28, 2024 | globenewswire.com

Endonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Inc

March 4, 2024 | finance.yahoo.com

Endonovo’s SofPulse® to Be Featured at Innovative Pain Management Solutions

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

March 4, 2024 | globenewswire.com

Endonovo's SofPulse® to Be Featured at Innovative Pain Management Solutions

December 4, 2023 | finance.yahoo.com

Endonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Million

November 21, 2023 | finance.yahoo.com

Endonovo Therapeutics, Inc. (ENDV)

November 15, 2023 | investing.com

Lexeo Therapeutics Inc (LXEO)

October 13, 2023 | msn.com

Endonovo receives Taiwanese approval for SofPulse technology

April 16, 2024 | Manward Press (Ad)

Can't believe it's happening again

October 12, 2023 | finance.yahoo.com

Endonovo's SofPulse® Secures Taiwan FDA Approval

August 22, 2023 | finance.yahoo.com

Endonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distribution

August 8, 2023 | finance.yahoo.com

Endonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Update

June 22, 2023 | finance.yahoo.com

New to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.

June 22, 2023 | finance.yahoo.com

New to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.

June 7, 2023 | finance.yahoo.com

Endonovo Pending Agreement to Develop Telehealth Division

May 2, 2023 | finance.yahoo.com

Endonovo Launches SofPulse® into the Veterans Administration

April 25, 2023 | finance.yahoo.com

Endonovo Reaches Out to Top Clinical Researchers to Collaborate on TBI Treatment Studies

April 13, 2023 | finance.yahoo.com

Endonovo Announces Partnership with Former NFL Dallas Cowboy Defensive Lineman

April 10, 2023 | finance.yahoo.com

Endonovo Announces Partnership with Santana Lead Singer Andy Vargas

March 29, 2023 | finance.yahoo.com

Endonovo Announces Binding Letter of Intent to Sell SofPulse® Assets to Spin-Off Company

March 23, 2023 | finance.yahoo.com

Endonovo’s SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in Taiwan

March 15, 2023 | finance.yahoo.com

Olympian and Champion Surfer Carlos Muñoz Turns To SofPulse® For Accelerated Recovery After Invasive Shoulder Surgery

March 9, 2023 | finance.yahoo.com

Endonovo Therapeutics (OTCMKTS:ENDV) Reaches Distribution Agreement with Academy Medical

March 6, 2023 | finance.yahoo.com

Endonovo Announces Distribution Agreement with Academy Medical

February 28, 2023 | finance.yahoo.com

Endonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira Weisberg

January 31, 2023 | finance.yahoo.com

Endonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-Off

January 26, 2023 | finance.yahoo.com

Endonovo Partners with International Distributor for SofPulse® Line

See More Headlines

Receive ENDV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Endonovo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/16/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Electromedical equipment
Sub-Industry: N/A
Current Symbol: OTCMKTS:ENDV
CUSIP: N/A
CIK: 1528172
Web: www.endonovo.com
Phone: (800) 489-4774
Fax: 818-230-9899
Employees: 1
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-18,480,000.00
Net Margins: -1,717.21%
Pretax Margin: -1,717.21%
Return on Equity: N/A
Return on Assets: -408.63%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $140,000.00
Price / Sales: 7.61
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.15) per share
Price / Book: -0.02

Miscellaneous

Outstanding Shares: 333,040,000
Free Float: 314,355,000
Market Cap: $1.07 million
Optionable: Not Optionable
Beta: -1.41

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Mr. Alan Brian Collier (Age 58)
Chairman & CEO
Comp: $300k
Mr. Don Calabria
Vice President of Operations
Mr. Garry Michael Kann
Head of Corporate Development
Mr. Ira Weisberg (Age 75)
President & Chief Commercial Officer of Medical Division

Key Competitors

View All Competitors

ENDV Stock Analysis - Frequently Asked Questions

How have ENDV shares performed in 2024?: Endonovo Therapeutics' stock was trading at $0.0087 on January 1st, 2024. Since then, ENDV shares have decreased by 63.2% and is now trading at $0.0032.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Endonovo Therapeutics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Endonovo Therapeutics investors own include Chesapeake Energy (CHKAQ), Energous (WATT), Advanced Micro Devices (AMD), BioLineRx (BLRX), Ekso Bionics (EKSO), Geron (GERN), Marinus Pharmaceuticals (MRNS), Micron Technology (MU), Novavax (NVAX) and Exxon Mobil (XOM).
How do I buy shares of Endonovo Therapeutics?: Shares of ENDV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ENDV) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Endonovo Therapeutics (ENDV) Stock Price, News & Analysis

About Endonovo Therapeutics Stock (OTCMKTS:ENDV)

ENDV Stock Price History

ENDV Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ENDV Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info